Literature DB >> 10464528

[Caffeine skinned fiber tension test: application to the diagnosis of susceptibility to malignant hyperthermia].

P Adnet1, M L Börtlein, B Tavernier, Y Nivoche, T Etchrivi, R Krivosic-Horber, G Haudecoeur.   

Abstract

OBJECTIVE: To assess the reactivity of sarcoplasmic reticulum to caffeine, using the skinned muscle fibre tension test and to compare it with the reference in vitro contracture test in the diagnosis of malignant hyperthermia (HM) susceptibility. STUDY
DESIGN: Laboratory investigation. MATERIAL: Muscle biopsies from 63 patients, including 29 classified as susceptible to MH (MHS) and 34 classified as non-susceptible (MHN) according to criteria of the European and the North American MH groups.
METHOD: The reactivity to caffeine and halothane of skinned muscle fibres was compared, according to the type of fibres, with the data of the in vitro contracture test. The type of fibres (type I: oxidative, slow; type II: glycolytic, fast) were determined with strontium dose-response curves.
RESULTS: The reactivity to caffeine was significantly lower in the MHS group, for both type I and type II skinned fibres. However, in comparison with the data of the in vitro contracture tests, using the ROC curve analysis, the best sensitivity-specificity compromise was 90%-71% and 74%-84% for type I and type II skinned fibres respectively.
CONCLUSION: The skinned muscle fibre tension test cannot be used instead of the in vitro contracture test for the diagnostic of MHS. However, it may strengthen the data of the latter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464528     DOI: 10.1016/s0750-7658(99)80148-8

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  1 in total

1.  [A randomized study of gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin as the 1st line chemotherapy for advanced non-small cell lung cancer in elderly patients].

Authors:  Zhixi Li; Mei Hou; Haiyan Wang; Zeyang Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.